March 1, 2001

1 Min Read
Nutraceutix's CDT Being Used in Pain Medication


Nutraceutix's CDT Being Used in Pain Medication

REDMOND, Wash.--Nutraceutix Inc. has entered into an agreementwith Lehigh Valley Technologies, based in Allentown, Pa., to co-develop Tramadol,a prescription pain medication, using Nutraceutix's patented controlled deliverytechnology (CDT). According to Nutraceutix, the use of CDT will allow a steady,programmed release of the active ingredient over time for optimal absorption.

"We are pleased to be working with Lehigh Valley Technologies,"said David Howard, president and chief executive officer of Nutraceutix."The co-development of CDT Tramadol is an important step in the growth ofNutraceutix's prescription drug franchise." Nutraceutix is online at www.nutraceutix.com.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like